HLB Pharmaceutical Co. Ltd (047920) — Free Cash Flow Generation Index
HLB Pharmaceutical Co. Ltd (047920) has a Free Cash Flow Generation Index of -0.21x as of September 2025. Free cash flow of ₩-391.04 Million represents 0% of operating cash flow (₩1.86 Billion). Explore 047920 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
HLB Pharmaceutical Co. Ltd Free Cash Flow Generation Index (2014–2024)
Historical FCF Generation Index trend for HLB Pharmaceutical Co. Ltd across 3 annual periods. For the full cash flow conversion analysis, see HLB Pharmaceutical Co. Ltd (047920) cash flow conversion.
Annual Free Cash Flow Generation for HLB Pharmaceutical Co. Ltd (2014–2024)
Year-by-year Free Cash Flow Generation Index for HLB Pharmaceutical Co. Ltd. Check HLB Pharmaceutical Co. Ltd (047920) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.55x | ₩3.75 Billion | ₩6.84 Billion | ₩3.09 Billion | ▼ -73.0% |
| 2019 | 2.03x | ₩2.75 Billion | ₩1.35 Billion | ₩1.40 Billion | ▼ -17.6% |
| 2014 | 2.47x | ₩3.80 Billion | ₩1.54 Billion | ₩2.26 Billion | — |